SEARCH

SEARCH BY CITATION

References

  • 1
    Byrne RL, Leung H, Neal DE. Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J Urol 1996; 77: 62733
  • 2
    Baserga R, Resnicoff M, D'Ambrosio C, Valenitis B. The role of the IGF-1 receptor in apoptosis. Vitamins Hormone 1997; 53: 6598
  • 3
    Hirscberg R. Insulin-like growth factor in the kidney. Miner Electrolyte Metab 1996; 22: 12832
  • 4
    Bereket A, Lang CH, Blethen SL, Kaskel FJ, Stewart C, Wilson TA. Growth hormone treatment in growth retarded children with end stage renal failure: effect on free/dissociable IGF-1 levels. J Pediatr Endocrinol Metab 1997; 10: 197202
  • 5
    Juul A, Holm K, Kastrup KW et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 2497502
  • 6
    Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal and hypophysectomized rats. J Clin Invest 1986; 77: 176875
  • 7
    Guler HP, Zapf J, Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 1987; 317: 13740
  • 8
    Cohen P, Peehl DM, Stamet TA, Wilson KF, Clemmons DK, Rosenfeld RG. Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endoc Metab 1993; 76: 10315
  • 9
    Kanety H, Madjar Y, Dagan Y et al. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP is decreased in patients with prostate cancer correlation with serum prostate specific antigen. J Clin Endoc Metab 1993; 77: 22933
  • 10
    Ho PJ & Baxter RC. Insulin-like growth factor binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endoc 1997; 46: 33342
  • 11
    Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997; 76: 11158
  • 12
    Grayhack JT, Lee C, Oliver L, Schaeffer AJ, Wendel EF. Biochemical profiles of prostatic fluid from normal and diseased prostate glands. Prostate 1980; 1: 22737
  • 13
    Miles LEM, Lipschitz DA, Bieber CP, Cook JD. Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem 1974; 61: 20924
  • 14
    Grant ES, Ross MB, Ballard S, Naylor A, Habib FK. The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells. J Clin Endocrinol Metab; 1998 83: 32527
  • 15
    Shimasaki S & Ling N. Identification and molecular characterisation of insuline-lik growth factor binding proteins. Prog Growth Factor Res 1991; 3: 24366
  • 16
    Cohen P, Peehl DM, Lamson G, Rosenfeld RG. Insulin-like growth factors, IGF receptors and IGF binding proteins in primary culture of prostate epithelial cells. J Clin Endocrinol Metabol 1991; 73: 4017
  • 17
    Cutting CWM, Hunt C, Nisbet JA, Bland JM, Dalgleish AG, Kirby RS. Serum insulin-like growth factor-1 is not a usful marker of prostate cancer. Br J Urol 1999; 83: 9969
  • 18
    Juul A, Bang P, Hertel NT et al. Serum insulin-like growth factor-1 in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endoc Metab 1994; 78: 74452
  • 19
    Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. The ratio between serum levels of insulin-like growth factor (IGF)-1 and the IGF binding proteins (IGFBP-1,2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endoc 1994; 41: 8593
  • 20
    Goodman-Gruen D & Barrett-Conor E. Epidemiology of insulin-like growth factor-1 in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997; 145: 9706
  • 21
    Kirschner BS & Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterol 1986; 91: 8306
  • 22
    Wu JC, Daughaday WH, Lee SD et al. Radioimmunoassay of serum IGF-1 and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. J Lab Clin Med 1988; 112: 58994

Authors

  1. Authors

H. Perk, MD, Assistant Professor of Urology.

T.A. Serel, MD, Associate Professor of Urology.

N. Delibas, MD, Associate Professor of Biochemistry.

R. Sütçü, MD, Research Assistant in Biochemistry.

Abbreviations
IRMA

immunoradiometric assay.